AI-Discovered Drug Enters Phase II: Transforming the Future of Clinical Trials For the first time in history, a drug designed entirely by generative artificial intelligence has moved into Phase II clinical trials with patients. INS018_055, developed by Insilico Medicine , target... AI drug discovery biotechnology clinical trials drug development generative AI pharma innovation pulmonary fibrosis